Skip to content

Hyloris

Active
Public limited companyfounded 20179 yrs activeBoulevard de Patience et Beaujonc 3, 4000 Liège, BelgiumKBO/BCE: BE 0669.738.676
Summary

Hyloris has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €706,225 and a net result of -€100,517. Equity is shrinking by ~12.5% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2026. Its solvency ranks better than 49% of 5071 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability40▲+10
Solvency70▲+70
Growth68▲+10
Track record100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35,000 at 30 days acceptable
Liquidity tight (current ratio 1.35 against 0.24 in 2024; short-term debt: 55.3% and cash: 18.9% of total assets), and 55.3% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
24 d early
2024
27 d early
2023
107 d late
2022
20 d early
2021
19 d early
2020
25 d early
2019
1 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 1 day before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 11 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 18 January 2017, Hyloris was incorporated.1 Revenue went from EUR 53,250 in 2023 to EUR 384,852 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2023 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€384,852▲ 623%
2023 · €53,250
EBIT margin
11.6%▲ 193.9pp
2023 · -182.3%
Net result
-€100,517
2024 · €22,759
Working capital
€304,825
2024 · -€2.0m
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover€53,250€384,852
Operating result-€139,370▲ 78.6%-€77,148▲ 44.6%-€97,070▼ 25.8%€168,568€44,569▼ 73.6%
Net result-€235,780below the sector's middle half▲ 64.2%-€148,510below the sector's middle half▲ 37.0%-€146,630below the sector's middle half▲ 1.3%€22,759within the sector's middle half-€100,517below the sector's middle half
EBIT margin-182.3%11.6%
Equity-€1.4mbelow the sector's middle half▼ 19.9%-€1.6mbelow the sector's middle half▼ 10.5%-€1.7mbelow the sector's middle half▼ 9.3%-€1.7mbelow the sector's middle half▲ 1.3%€706,225within the sector's middle half
Total assets€3.9mwithin the sector's middle half▼ 69.3%€722,414below the sector's middle half▼ 81.4%€1.0mwithin the sector's middle half▲ 41.2%€996,554below the sector's middle half▼ 2.3%€1.6mwithin the sector's middle half▲ 58.4%
Debt€5.3m▼ 61.7%€2.3m▼ 56.8%€2.7m▲ 19.4%€2.7m▼ 1.7%€872,164▼ 67.6%
Working capital€3.9mabove the sector's middle half▼ 69.0%€707,895within the sector's middle half▼ 81.6%€624,010within the sector's middle half▼ 11.8%-€2.0mbelow the sector's middle half€304,825within the sector's middle half
Solvency-36.5%below the sector's middle half▼ 27.2pp-217.2%below the sector's middle half▼ 180.7pp-168.2%below the sector's middle half▲ 49.0pp-169.9%below the sector's middle half▼ 1.7pp44.7%within the sector's middle half▲ 214.7pp
Current ratio49.76above the sector's middle half5.26above the sector's middle half▼ 44.500.24below the sector's middle half▼ 5.021.35within the sector's middle half▲ 1.11
Return on assets (ROA)-6.1%below the sector's middle half▼ 0.9pp-20.6%below the sector's middle half▼ 14.5pp-14.4%below the sector's middle half▲ 6.2pp2.3%within the sector's middle half▲ 16.7pp-6.4%below the sector's middle half▼ 8.7pp
above within below the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€400,000-€200,000€0€200,000Operating result 2021: -€139,370-€139,370Net result 2021: -€235,780-€235,780Operating result 2022: -€77,148-€77,148Net result 2022: -€148,510-€148,510Operating result 2023: -€97,070-€97,070Net result 2023: -€146,630-€146,630Operating result 2024: €168,568€168,568Net result 2024: €22,759€22,759Operating result 2025: €44,569€44,569Net result 2025: -€100,517-€100,51720212022202320242025-€200,000-€100,000€0€100,000€200,000Operating result 2023: -€97,070-€97,100Net result 2023: -€146,630-€147,000Operating result 2024: €168,568€169,000Net result 2024: €22,759€22,800Operating result 2025: €44,569€44,600Net result 2025: -€100,517-€101,000202320242025
The operating result falls in 2025; 2025 is 74% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.6m
Fixed assets €401,400 ▲ 13.7%
Current assets €1.2m ▲ 82.9%
Equity and liabilities €1.6m
Equity €706,225
Debt €872,164
Debt finances 55.3% of the balance-sheet total.
Key figures and ratios
2025 value · change against 2024
EBITDA
€69,597▼
2024 · €170,090
Cash flow
-€75,489▼
2024 · €24,281
Quick ratio
1.29▲
2024 · 0.24
Debt to equity
1.23
ROE
-14.2%
Interest coverage
0.43▼
2024 · 0.98
Debt ≤ 1 year
€872,164▼
2024 · €2.7m
Income taxes
€3,433▲
2024 · -€9,317
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 929 companies that looked in July 2024 the way this one looks now, 1.7% went bankrupt within 24 months and 93% are still going.

  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a small loss
1.7% went bankrupt
5.6% stopped otherwise
93% still going

For this company itself Checked computes a bankruptcy probability of 0.6% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 929 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 40 lines
Balance sheet Code20242025
Assets
Total assets20/58€996,554€1.6m▲
Fixed assets21/28€353,175€401,400▲
Intangible fixed assets21€353,175€401,400▲
Current assets29/58€643,379€1.2m▲
Amounts receivable after more than one year29€43,048€30,703▼
Other amounts receivable291€43,048€30,703▼
Stocks and contracts in progress3-€51,748
Stocks30/36-€51,748
Amounts receivable within one year40/41€19,812€795,880▲
Trade receivables40-€764,855
Other amounts receivable41€19,812€31,025▲
Cash at bank and in hand54/58€580,519€298,658▼
Equity and liabilities
Total equity and liabilities10/49€996,554€1.6m▲
Equity10/15-€1.7m€706,225▲
Contributions10/11€62,000€806,742▲
Capital10€62,000€806,742▲
Issued capital100€62,000€806,742▲
Profit (loss) carried forward14-€1.8m-€100,517▲
Amounts payable17/49€2.7m€872,164▼
Amounts payable within one year42/48€2.7m€872,164▼
Trade debts44€100,052€244,208▲
Suppliers440/4€100,052€244,208▲
Other amounts payable47/48€2.6m€627,956▼
Income statement Code20242025
Turnover70-€384,852
Goods, raw materials, services and sundry goods60/61-€870,009
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,522€25,028▲
Provisions for liabilities and charges: additions (uses and reversals)635/8--€36,343
Other operating charges640/8€607€3,341▲
Gross operating margin9900€170,697€36,595▼
Operating profit (loss)9901€168,568€44,569▼
Financial income75/76B€18,896€19,930▲
Recurring financial income75€18,896€19,930▲
Financial charges65/66B€174,022€161,583▼
Recurring financial charges65€174,022€161,583▼
Profit (loss) for the period before taxes9903€13,442-€97,084▼
Income taxes67/77-€9,317€3,433▲
Profit (loss) for the period9904€22,759-€100,517▼
Profit (loss) for the period to be appropriated9905€22,759-€100,517▼
Appropriation of the result
Profit (loss) to be appropriated9906-€1.8m-€100,517▲
Profit (loss) brought forward from the previous period14P-€1.8m€0▲

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Turnover70--€53,250-€384,852-
Non-recurring operating income76A€17,110-----
Goods, raw materials, services and sundry goods60/61-€4,352€18,787-€870,009-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€153,427€71,486€130,058€1,522€25,028▲ 1,544%
Provisions for liabilities and charges: additions (uses and reversals)635/8-----€36,343-
Other operating charges640/8€916€1,310€1,475€607€3,341▲ 450%
Non-recurring operating charges66A€0-----
Gross operating margin9900€14,973-€4,352€34,463€170,697€36,595▼ 78.6%
Operating profit (loss)9901-€139,370-€77,148-€97,070€168,568€44,569▼ 73.6%
Financial income75/76B€2,188-€24,092€18,896€19,930▲ 5.5%
Recurring financial income75€2,188-€24,092€18,896€19,930▲ 5.5%
Financial charges65/66B€110,951€73,774€84,723€174,022€161,583▼ 7.1%
Recurring financial charges65€110,951€73,774€84,723€174,022€161,583▼ 7.1%
Profit (loss) for the period before taxes9903-€248,133-€150,922-€157,701€13,442-€97,084▼ 822%
Income taxes67/77-€12,353-€2,412-€11,071-€9,317€3,433▲ 137%
Profit (loss) for the period9904-€235,780-€148,510-€146,630€22,759-€100,517▼ 542%
Profit (loss) for the period to be appropriated9905-€235,780-€148,510-€146,630€22,759-€100,517▼ 542%
Line20212022202320242025Change
Assets
Total assets20/58€3.9m€722,414€1.0m€996,554€1.6m▲ 58.4%
Fixed assets21/28--€249,387€353,175€401,400▲ 13.7%
Intangible fixed assets21--€249,387€353,175€401,400▲ 13.7%
Current assets29/58€3.9m€722,414€770,535€643,379€1.2m▲ 82.9%
Amounts receivable after more than one year29€29,269€31,681€44,488€43,048€30,703▼ 28.7%
Other amounts receivable291€29,269€31,681€44,488€43,048€30,703▼ 28.7%
Stocks and contracts in progress3----€51,748-
Stocks30/36----€51,748-
Amounts receivable within one year40/41€2,193€307€25,326€19,812€795,880▲ 3,917%
Trade receivables40--€13,612-€764,855-
Other amounts receivable41€2,193€307€11,714€19,812€31,025▲ 56.6%
Cash at bank and in hand54/58€3.9m€690,426€699,207€580,519€298,658▼ 48.6%
Deferred charges and accrued income490/1€0-€1,514---
Equity and liabilities
Total equity and liabilities10/49€3.9m€722,414€1.0m€996,554€1.6m▲ 58.4%
Equity10/15-€1.4m-€1.6m-€1.7m-€1.7m€706,225▲ 142%
Contributions10/11€62,000€62,000€62,000€62,000€806,742▲ 1,201%
Capital10€62,000€62,000€62,000€62,000€806,742▲ 1,201%
Issued capital100€62,000€62,000€62,000€62,000€806,742▲ 1,201%
Profit (loss) carried forward14-€1.5m-€1.6m-€1.8m-€1.8m-€100,517▲ 94.3%
Amounts payable17/49€5.3m€2.3m€2.7m€2.7m€872,164▼ 67.6%
Amounts payable after more than one year17€5.1m€2.1m€2.3m---
Financial debts170/4€5.1m€2.1m€2.3m---
Amounts payable within one year42/48€31,692€14,519€146,525€2.7m€872,164▼ 67.6%
Trade debts44€31,692€14,519€146,525€100,052€244,208▲ 144%
Suppliers440/4€31,692€14,519€146,525€100,052€244,208▲ 144%
Other amounts payable47/48---€2.6m€627,956▼ 75.8%
Accrued charges and deferred income492/3€168,264€176,160€258,410---
Line20212022202320242025Change
Profit (loss) for the period9904-€235,780-€148,510-€146,630€22,759-€100,517▼ 542%
+ Depreciation and write-downs630€153,427€71,486€130,058€1,522€25,028▲ 1,544%
Operating cash flow (approximation)-€82,353-€77,024-€16,572€24,281-€75,489▼ 411%
Investment in fixed assets (approximation)----€105,310-€73,253▲ 30.4%
Change in cash--€3.2m€8,781-€118,688-€281,861▼ 137%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
07-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial Liquidity times 6current ratio 1.35
Current ratio from 0.24 to 1.35; short-term debt falls from €2.7m to €872,164.
31-12
Financial Equity above €500,000Eq €706,225
Equity rises from -€1.7m to €706,225.
04-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial Back to profitnet €22,759
Net result €22,759 after 6 loss-making years.
15-11
NBB filing Annual accounts filed
fiscal year 2023 · full schema · 107 days late
2023
11-07
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
12-07
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial Liquidity doublescurrent ratio 122.72
Current ratio from 59.93 to 122.72; short-term debt falls from €211,329 to €31,692.
06-07
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial Weakest financial yearnet -€659,044
Net result drops to -€659,044, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity times 109current ratio 59.93
Current ratio from 0.55 to 59.93.
30-07
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
26-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 26 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 12 acts read
About the unread acts

We know of 12 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 12 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Liège · 1 establishment unit since 2017
seat establishment The establishment unit on the map
Ground area
1.9 ha
Parcel 62042B0366/00B003, Wallonia. Linked by address, not a title deed.
43 companies at this address See who is registered here
1 establishment unit
Boulevard de Patience et Beaujonc 3, 4000 Liège
Manufacture of basic pharmaceutical products and pharmaceutical preparations
since 20172.262.641.596
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62042B0366/00B003 Wallonia 1.9 ha - -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 owner

Chain of control

  1. Hyloris Pharmaceuticals 100%
  2. Hyloris

Highest known parent: Hyloris Pharmaceuticals. The sources do not say who stands above it.

Owners 1

Holdings 0

No holding stated in the accounts, acts or LEI register we read.

According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 1,901 companies in this sector we hold annual accounts for 1,126. 778 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPublic limited company
Founded18-01-2017
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
E-invoicing
Reachable via Peppol
Peppol ID 0208:0669738676
Registered 21-10-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.